Cipla pledges support to ‘Terra Carta’, for a sustainable future Kumar Jeetendra | March 19, 2021 Mumbai; March 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has pledged support to ‘Terra Carta’, a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales’ Sustainable Markets …
Piramal Enterprises to take care of COVID vaccination costs for representatives taking jabs in India Kumar Jeetendra | March 15, 2021 Piramal Enterprises on Monday said it will pay for the cost of COVID-19 vaccination for all its employees and their immediate family members that get the jabs in India. The business will absorb the cost of COVID-19 vaccination for all its employees and their immediate family members who are eligible and choose to get the …
Sun Pharma, Dr Reddy’s, Aurobindo recall products in the U.S. market Kumar Jeetendra | March 14, 2021 Leading home grown drug makers Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are remembering products in the U.S. market, the world’s largest market for pharmaceutical products, for various reasons. As per the latest Enforcement Report from the U.S. Food and Drug Administration (USFDA), Sun Pharma is remembering Cequa ophthalmic solution, which is …
Sanofi to begin human preliminaries of its second COVID vaccine candidate Kumar Jeetendra | March 12, 2021 French pharmaceutical company Sanofi on Friday announced the launch of human trials of its next COVID-19 vaccine, with its first still in the testing period after having fallen behind in development. Sanofi and US firm Translate Bio are growing the vaccine based on messenger RNA technology. The phase 1 and 2 trials aim to confirm …
Dr Reddy’s gets 3 perceptions from USFDA for US-based API plant Kumar Jeetendra | March 10, 2021 Dr Reddy’s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its Production facility in Middleburg, New York. The audit of the business’s active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed from the US Food and Drug Administration (USFDA), the Hyderabad-based …
Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index Kumar Jeetendra | March 8, 2021 Global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and development, manufacturing, and government policy and regulation. Respondents answered questions on a scale of 1 to 10 in …
Natco Pharma rises after USFDA gesture for cancer treatment drug Kumar Jeetendra | March 8, 2021 Natco Pharma jumped 6.2% to Rs 884.35 after the company received final approval for everolimus tablets in the US market. Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for its abbreviated new drug application (ANDA) for everolimus tablets (a generic version of Afinitor) from the US Food and …
Oxford study demonstrates AstraZeneca powerful against Brazil variant, source says Kumar Jeetendra | March 6, 2021 Preliminary data from a study conducted at the University of Oxford suggests that the COVID-19 vaccine developed by AstraZeneca PLC is successful against the P1, or Brazilian, version, a source with knowledge of the study told Reuters on Friday. The data suggests that the vaccine won’t need to be modified so as to safeguard against …
Alembic Pharma JV packs USFDA gesture on testosterone gel Kumar Jeetendra | March 4, 2021 Alembic Pharmaceuticals announced that its joint venture (JV), Aleor Dermaceuticals has obtained the final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) for testosterone gel, 1.62%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), AndroGel 1.62%, of AbbVie Inc. (AbbVie). Testosterone gel, 1.62% (20.25 mg/1.25 …
Unichem Laboratories Ltd gets ANDA endorsement for Guanfacine Tablets Kumar Jeetendra | March 4, 2021 Unichem Laboratories Limited has obtained ANDA approval for its Guanfacine Tablets, USP 1 mg and 2 mg in the United States Food and Drug Administration (USFDA) to market a generic version of TENEX® (Guanfacine) Tablets 1 mg and 2 mg of Promius Pharma LLC. Guanfacine Tablets are indicated in the management of hypertension. The product …
J&J CEO Alex Gorsky sees COVID-19 shots in American arms in 1-2 days as transportation begins Kumar Jeetendra | March 2, 2021 Johnson & Johnson’s newly authorized COVID-19 vaccine has begun shipping and its top executive said on Monday that Americans should have the ability to get the single-dose shot over the next 24 to 48 hours, including a third vaccine in america. The drugmaker intends to deliver 4 million vaccine doses this week, 20 million by …
Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg) Kumar Jeetendra | March 2, 2021 Mumbai, India, March 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ hereinafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug Administration (U.S. FDA). Cipla’s Sumatriptan Nasal Spray USP, 20 mg …
